Filing metadata

Accession number
0001808821-26-000005
Form type
Form 3
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Mar 16, 2026
Reporting period
Mar 09, 2026
Description
Initial ownership

Explore SEC Filings Hub